The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Meta-analysis shows strong positive association of the neuregulin 1 ( NRG1 ) gene with schizophrenia
Abstract
Chromosome 8p22-p11 has been identified as a locus for schizophrenia in several genome-wide scans and confirmed by meta-analysis of published linkage data. Systematic fine mapping using extended Icelandic pedigrees identified an associated haplotype in the gene neuregulin 1 (NRG1), also known as heuregulin, glial growth factor, NDF43 and ARIA. A 290 kb core at risk haplotype at the 5' end of the gene (HAP(ICE)), defined by five SNPs and two microsatellite polymorphisms was found to be associated with schizophrenia in the Icelandic and Scottish populations. A number of subsequent independent studies have attempted to replicate the association, and while some have been successful, the associated haplotype is not always HAP(ICE). Furthermore, no obviously functional or pathogenic variants have been identified, and the relationship between the gene and schizophrenia has remained inconclusive. To reconcile these conflicting findings and to give a comprehensive picture of the genetic architecture of this important gene, we performed a meta-analysis of 13 published population-based and family-based association studies up to November 2005. We analysed data from the SNP markers SNP8NRG241930, SNP8NRG243177, SNP8NRG221132 and SNP8NRG221533, and the microsatellite markers 478B14-848, 420M9-1395. Across these studies, strong positive association was found for all six polymorphisms. The haplotype analysis also showed significant association in the pooled international populations (OR=1.22, 95% CI 1.15-1.3, P=8 x 10(-10)). In Asian populations, the risk haplotype was focused around the two microsatellite markers, 478B14-848, 420M9-1395 (haplotype block B), and in Caucasian populations with the remaining four SNP markers (haplotype block A). This meta-analysis supports the involvement of NRG1 in the pathogenesis of schizophrenia, but with association between two different but adjacent haplotypes blocks in the Caucasian and Asian populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“ORs were pooled using the method of DerSimonian and Laird (45), and 95% CIs were constructed using Woolf’s method (46).”
MethodON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
WOOLF, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,723
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Neuregulin 1 and Susceptibility to Schizophrenia
Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342734 · Cited by 1,683
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,137
Neuregulins: functions, forms, and signaling strategies
Falls, D. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00102-7 · Cited by 1,071
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811 · cited 1×
“5%), but had an exceedingly low incidence in Asians, and was actually undetectable in the Chinese population where allele (4) was found instead.”
BackgroundGenes for schizophrenia? Recent findings and their pathophysiological implications
Harrison, P. J., & Owen, M. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12379-3 · Cited by 597
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577 · cited 1×
“Recently, whole-genome linkage scan (4–6) and functional studies (3,7,8) have implicated several promising positional candidates pointing more towards the glutamate pathway, (9) the most attractive of which has been the neuregulin 1 (NRG1) gene (3,5–8).”
BackgroundGenome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part III: Bipolar Disorder
Segurado, R., Detera-Wadleigh, S. D., Levinson, D. F., Lewis, C. M., Gill, M., Nurnberger, J. I., Craddock, N., DePaulo, J. R., Baron, M., Gershon, E. S., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376547 · Cited by 569
Association of Neuregulin 1 with Schizophrenia Confirmed in a Scottish Population
Stefansson, H., Sarginson, J., Kong, A., Yates, P., Steinthorsdottir, V., Gudfinnsson, E., Gunnarsdottir, S., Walker, N., Petursson, H., Crombie, C., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/345442 · Cited by 559
Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21
Blouin, J.-L., Dombroski, B. A., Nath, S. K., Lasseter, V. K., Wolyniec, P. S., Nestadt, G., Thornquist, M., Ullrich, G., McGrath, J., Kasch, L., et al. (1998) · Nature Genetics · doi:10.1038/1734 · Cited by 534
Neuregulin and ErbB receptor signaling pathways in the nervous system
Buonanno, A., & Fischbach, G. D. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00210-5 · Cited by 505
Epidemiology of schizophrenia: the global burden of disease and disability
Jablensky, A. (2000) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060070002 · Cited by 460
Cannon, T. D., Kaprio, J., Lönnqvist, J., Huttunen, M., & Koskenvuo, M. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.67 · Cited by 456
Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia
Corfas, G., Roy, K., & Buxbaum, J. D. (2004) · Nature Neuroscience · doi:10.1038/nn1258 · Cited by 388
Wheeler, J. G., Keavney, B. D., Watkins, H., Collins, R., & Danesh, J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15642-0 · Cited by 317
Wolpowitz, D., Mason, T. B. A., Dietrich, P., Mendelsohn, M., Talmage, D. A., & Role, L. W. (2000) · Neuron · doi:10.1016/s0896-6273(00)80873-9 · Cited by 313
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia
Hashimoto, R., Straub, R. E., Weickert, C. S., Hyde, T. M., Kleinman, J. E., & Weinberger, D. R. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001434 · Cited by 283
Pulver, A. E., Lasseter, V. K., Kasch, L., Wolyniec, P., Nestadt, G., Blouin, J., Kimberland, M., Babb, R., Vourlis, S., Chen, H., et al. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320600316 · Cited by 255
Association study of neuregulin 1 gene with schizophrenia
Yang, J. Z., Si, T. M., Ruan, Y., Ling, Y. S., Han, Y. H., Wang, X. L., Zhou, M., Zhang, H. Y., Kong, Q. M., Liu, C., et al. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001377 · Cited by 239
Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia
Williams, N. M., Preece, A., Spurlock, G., Norton, N., Williams, H. J., Zammit, S., O'Donovan, M. C., & Owen, M. J. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001348 · Cited by 234
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1534 · Cited by 201
Support for involvement of neuregulin 1 in schizophrenia pathophysiology
Petryshen, T. L., Middleton, F. A., Kirby, A., Aldinger, K. A., Purcell, S., Tahl, A. R., Morley, C. P., McGann, L., Gentile, K. L., Rockwell, G. N., et al. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001608 · Cited by 197
Bray, N. J., Preece, A., Williams, N. M., Moskvina, V., Buckland, P. R., Owen, M. J., & O'Donovan, M. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi199 · Cited by 186
Li, T., Stefánsson, H., Gudfinnsson, E., Cai, G., Liu, X., Murray, R. M., Steinthórsdóttir, V., Januel, D., Gudnadottir, V. G., Pétursson, H., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001485 · Cited by 169
Self-citationMultiple novel transcription initiation sites for NRG1
Steinthorsdottir, V., Stefansson, H., Ghosh, S., Birgisdottir, B., Bjornsdottir, S., Fasquel, A. C., Olafsson, O., Stefansson, K., & Gulcher, J. R. (2004) · Gene · doi:10.1016/j.gene.2004.07.029 · Cited by 168
Neuregulin 1 and schizophrenia
Stefánsson, H., Steinthórsdóttir, V., Thorgeirsson, T. E., Gulcher, J. R., & Stefánsson, K. (2004) · Annals of Medicine · doi:10.1080/07853890310017585 · Cited by 166
Cho, H. J., Meira-Lima, I., Cordeiro, Q., Michelon, L., Sham, P., Vallada, H., & Collier, D. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001663 · Cited by 161
Self-citationCorvin, A. P., Morris, D. W., McGhee, K. A., Schwaiger, S., Scully, P. J., Quinn, J., Meagher, D. J., Clair, D. S., Waddington, J. L., & Gill, M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001412 · Cited by 147
Fan, J., & Sklar, P. B. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001690 · Cited by 141
The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia
Moises, H. W., Zoëga, T., & Gottesman, I. I. (2002) · BMC Psychiatry · doi:10.1186/1471-244x-2-8 · Cited by 133
The genetic epidemiology of schizophrenia in a finnish twin cohort
Cannon, T. D., Kaprio, J. A., Lönnqvist, J. K., HUTTUNEN, M. O., & Koskenvuo, M. J. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)82122-6 · Cited by 123
Association Between the Neuregulin 1 Gene and Schizophrenia: A Systematic Review
Tosato, S., Dazzan, P., & Collier, D. A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi043 · Cited by 115
Self-citationGlutamatergic aspects of schizophrenia
Tamminga, C. A. (1999) · The British Journal of Psychiatry · doi:10.1192/s0007125000293598 · Cited by 115
Thiselton, D. L., Webb, B. T., Neale, B. M., Ribble, R., O’Neill, F. A., Walsh, D., Riley, B. P., & Kendler, K. S. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001530 · Cited by 113
A case control and family based association study of the neuregulin1 gene and schizophrenia
Zhao, X., Shi, Y., Tang, J., Tang, R., Yu, L., Gu, N., Feng, G., Zhu, S., Liu, H., Xing, Y., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.014977 · Cited by 112
Self-citationTang, J. X., Chen, W., He, G., Zhou, J. P., Gu, N. F., Feng, G. Y., & He, L. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001436 · Cited by 107
Self-citationHall, D., Gogos, J. A., & Karayiorgou, M. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2004.00078.x · Cited by 104
No association with the neuregulin 1 haplotype to Japanese schizophrenia
Iwata, N., Suzuki, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Inada, T., & Ozaki, N. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001456 · Cited by 102
The genetics of schizophrenia: glutamate not dopamine?
Collier, D. A., & Li, T. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.105 · Cited by 99
Self-citationPulver, A. E., Mulle, J. G., Nestadt, G., Swartz, K., Blouin, J., Dombroski, B. A., Liang, K.-Y., Housman, D. E., Kazazian, H. H., Antonarakis, S. E., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000814 · Cited by 98
Chotai, J., Serretti, A., Lattuada, E., Lorenzi, C., & Lilli, R. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00112-4 · Cited by 79
Neuregulin 1: genetic support for schizophrenia subtypes
Bakker, S. C., Hoogendoorn, M. L. C., Selten, J.-P., Verduijn, W., Pearson, P. L., Sinke, R. J., & Kahn, R. S. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001564 · Cited by 79
Lee, S. (2001) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70238-0 · Cited by 66
Extreme population differences across Neuregulin 1 gene, with implications for association studies
Gardner, M. J., González‐Neira, A., Lao, Ó., Calafell, F., Bertranpetit, J., & Comas, D. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001749 · Cited by 63
Hong, C., Huo, S.-J., Liao, D., Lee, K., Wu, J.-Y., & Tsai, S. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.027 · Cited by 55
Neuregulin genotype and medication response in Finnish patients with schizophrenia
Kampman, O., Anttila, S. A. K., Illi, A., Saarela, M., Rontu, R., Mattila, K. M., Leinonen, E. V. J., & Lehtimäki, T. J. (2004) · Neuroreport · doi:10.1097/00001756-200411150-00017 · Cited by 53
Cited by
The epidermal growth factor receptor family: Biology driving targeted therapeutics
Wieduwilt, M. J., & Moasser, M. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7440-8 · Cited by 751
Neuregulin-ERBB Signaling in the Nervous System and Neuropsychiatric Diseases
Mei, L., & Nave, K.-A. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.007 · Cited by 592
Li, D., Sham, P. C., Owen, M. J., & He, L. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl152 · Cited by 586
Self-citationKeller, M. C., & Miller, G. (2006) · Behavioral and Brain Sciences · doi:10.1017/s0140525x06009095 · Cited by 540
Genomewide association for schizophrenia in the CATIE study: results of stage 1
Sullivan, P. F., Lin, D., Tzeng, J.-Y., van den Oord, E., Perkins, D., Stroup, T. S., Wagner, M., Lee, S., Wright, F. A., Zou, F., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.25 · Cited by 355
Metadata
- Authors
- Li, D., Collier, D. A., & He, L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-10
- Volume
- 15
- Issue
- 12
- Pages
- 1995-2002
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2146542524
- Cited by
- 295
- References
- 49
- FWCI
- 22.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.